Cargando…

The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article

BACKGROUND AND AIMS: HCQ gained importance following the National Task Force advisory as an anti-SARS-Cov-2 (coronavirus disease-2019 [COVID-19]) drug for frontline healthcare workers (including anesthesiologists). Report of a young anesthesiologist in Assam developing cardiac arrest following HCQ i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Shagun B., Pahade, Akhilesh, Chawla, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022063/
https://www.ncbi.nlm.nih.gov/pubmed/33840926
http://dx.doi.org/10.4103/joacp.JOACP_379_20
_version_ 1783674867373047808
author Shah, Shagun B.
Pahade, Akhilesh
Chawla, Rajiv
author_facet Shah, Shagun B.
Pahade, Akhilesh
Chawla, Rajiv
author_sort Shah, Shagun B.
collection PubMed
description BACKGROUND AND AIMS: HCQ gained importance following the National Task Force advisory as an anti-SARS-Cov-2 (coronavirus disease-2019 [COVID-19]) drug for frontline healthcare workers (including anesthesiologists). Report of a young anesthesiologist in Assam developing cardiac arrest following HCQ intake for COVID-19 prophylaxis made us even more concerned. A conscious decision has been made by a large majority among us––to have or not to have HCQ. However, less severe complications such as gastrointestinal upset, skin-rash, visual-disturbance, headache, and dizziness even if experienced by HCQ users were likely to go unreported unless shared. The present survey was conducted to assess the prevailing perception among Indian anesthesiologists about HCQ's preventive effect against COVID-19. The information has been pooled together and discussed in this study. MATERIAL AND METHODS: A total of 247 respondents participated in this pan-India survey. The survey questionnaire was prepared using “Google Forms” and conducted via links delivered through WhatsApp and electronic-mail. RESULTS: 55.9% (138/247) of the respondents had consumed HCQ, 38% (94/247) did not, and 6.1% (15/247) were undecided at the time of responding to the survey. In total, 47 respondents who ingested HCQ reported a side-effect, gastritis being the commonest (31). CONCLUSION: The evidence for the effectiveness of HCQ against COVID-19 in India is reportedly as strong and weak as other drugs that have been promoted. The survey highlights the reasons consumption of HCQ and represents the opinion of 247 practicing Indian anesthesiologists. It informs the benefits and side effects of HCQ, which can help others in reaching a balanced decision.
format Online
Article
Text
id pubmed-8022063
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80220632021-04-08 The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article Shah, Shagun B. Pahade, Akhilesh Chawla, Rajiv J Anaesthesiol Clin Pharmacol Original Article BACKGROUND AND AIMS: HCQ gained importance following the National Task Force advisory as an anti-SARS-Cov-2 (coronavirus disease-2019 [COVID-19]) drug for frontline healthcare workers (including anesthesiologists). Report of a young anesthesiologist in Assam developing cardiac arrest following HCQ intake for COVID-19 prophylaxis made us even more concerned. A conscious decision has been made by a large majority among us––to have or not to have HCQ. However, less severe complications such as gastrointestinal upset, skin-rash, visual-disturbance, headache, and dizziness even if experienced by HCQ users were likely to go unreported unless shared. The present survey was conducted to assess the prevailing perception among Indian anesthesiologists about HCQ's preventive effect against COVID-19. The information has been pooled together and discussed in this study. MATERIAL AND METHODS: A total of 247 respondents participated in this pan-India survey. The survey questionnaire was prepared using “Google Forms” and conducted via links delivered through WhatsApp and electronic-mail. RESULTS: 55.9% (138/247) of the respondents had consumed HCQ, 38% (94/247) did not, and 6.1% (15/247) were undecided at the time of responding to the survey. In total, 47 respondents who ingested HCQ reported a side-effect, gastritis being the commonest (31). CONCLUSION: The evidence for the effectiveness of HCQ against COVID-19 in India is reportedly as strong and weak as other drugs that have been promoted. The survey highlights the reasons consumption of HCQ and represents the opinion of 247 practicing Indian anesthesiologists. It informs the benefits and side effects of HCQ, which can help others in reaching a balanced decision. Wolters Kluwer - Medknow 2020 2020-11-05 /pmc/articles/PMC8022063/ /pubmed/33840926 http://dx.doi.org/10.4103/joacp.JOACP_379_20 Text en Copyright: © 2020 Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Shah, Shagun B.
Pahade, Akhilesh
Chawla, Rajiv
The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
title The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
title_full The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
title_fullStr The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
title_full_unstemmed The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
title_short The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
title_sort covid-19 hydroxychloroquine prophylaxis perception of indian anesthesiologists: a survey-based original article
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022063/
https://www.ncbi.nlm.nih.gov/pubmed/33840926
http://dx.doi.org/10.4103/joacp.JOACP_379_20
work_keys_str_mv AT shahshagunb thecovid19hydroxychloroquineprophylaxisperceptionofindiananesthesiologistsasurveybasedoriginalarticle
AT pahadeakhilesh thecovid19hydroxychloroquineprophylaxisperceptionofindiananesthesiologistsasurveybasedoriginalarticle
AT chawlarajiv thecovid19hydroxychloroquineprophylaxisperceptionofindiananesthesiologistsasurveybasedoriginalarticle
AT shahshagunb covid19hydroxychloroquineprophylaxisperceptionofindiananesthesiologistsasurveybasedoriginalarticle
AT pahadeakhilesh covid19hydroxychloroquineprophylaxisperceptionofindiananesthesiologistsasurveybasedoriginalarticle
AT chawlarajiv covid19hydroxychloroquineprophylaxisperceptionofindiananesthesiologistsasurveybasedoriginalarticle